Genetic Mapping of Novel Loci Affecting Canine Blood Phenotypes.

Since the publication of the dog genome and the construction of high-quality genome-wide SNP arrays, thousands of dogs have been genotyped for disease studies. For many of these dogs, additional clinical phenotypes are available, such as hematological and clinical chemistry results collected during...

Full description

Bibliographic Details
Main Authors: Michelle E White, Jessica J Hayward, Tracy Stokol, Adam R Boyko
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4690602?pdf=render
id doaj-9e0eb4adc4aa4eb8882878eafb44200a
record_format Article
spelling doaj-9e0eb4adc4aa4eb8882878eafb44200a2020-11-25T01:25:35ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011012e014519910.1371/journal.pone.0145199Genetic Mapping of Novel Loci Affecting Canine Blood Phenotypes.Michelle E WhiteJessica J HaywardTracy StokolAdam R BoykoSince the publication of the dog genome and the construction of high-quality genome-wide SNP arrays, thousands of dogs have been genotyped for disease studies. For many of these dogs, additional clinical phenotypes are available, such as hematological and clinical chemistry results collected during routine veterinary care. Little is known about the genetic basis of variation in blood phenotypes, but this variation may play an important role in the etiology and progression of many diseases. From a cohort of dogs that had been previously genotyped on a semi-custom Illumina CanineHD array for various genome-wide association studies (GWAS) at Cornell University Hospital for Animals, we chose 353 clinically healthy, adult dogs for our analysis of clinical pathologic test results (14 hematological tests and 25 clinical chemistry tests). After correcting for age, body weight and sex, genetic associations were identified for amylase, segmented neutrophils, urea nitrogen, glucose, and mean corpuscular hemoglobin. Additionally, a strong genetic association (P = 8.1×10-13) was evident between a region of canine chromosome 13 (CFA13) and alanine aminotransferase (ALT), explaining 23% of the variation in ALT levels. This region of CFA13 encompasses the GPT gene that encodes the transferase. Dogs homozygous for the derived allele exhibit lower ALT activity, making increased ALT activity a less useful marker of hepatic injury in these individuals. Overall, these associations provide a roadmap for identifying causal variants that could improve interpretation of clinical blood tests and understanding of genetic risk factors associated with diseases such as canine diabetes and anemia, and demonstrate the utility of holistic phenotyping of dogs genotyped for disease mapping studies.http://europepmc.org/articles/PMC4690602?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Michelle E White
Jessica J Hayward
Tracy Stokol
Adam R Boyko
spellingShingle Michelle E White
Jessica J Hayward
Tracy Stokol
Adam R Boyko
Genetic Mapping of Novel Loci Affecting Canine Blood Phenotypes.
PLoS ONE
author_facet Michelle E White
Jessica J Hayward
Tracy Stokol
Adam R Boyko
author_sort Michelle E White
title Genetic Mapping of Novel Loci Affecting Canine Blood Phenotypes.
title_short Genetic Mapping of Novel Loci Affecting Canine Blood Phenotypes.
title_full Genetic Mapping of Novel Loci Affecting Canine Blood Phenotypes.
title_fullStr Genetic Mapping of Novel Loci Affecting Canine Blood Phenotypes.
title_full_unstemmed Genetic Mapping of Novel Loci Affecting Canine Blood Phenotypes.
title_sort genetic mapping of novel loci affecting canine blood phenotypes.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description Since the publication of the dog genome and the construction of high-quality genome-wide SNP arrays, thousands of dogs have been genotyped for disease studies. For many of these dogs, additional clinical phenotypes are available, such as hematological and clinical chemistry results collected during routine veterinary care. Little is known about the genetic basis of variation in blood phenotypes, but this variation may play an important role in the etiology and progression of many diseases. From a cohort of dogs that had been previously genotyped on a semi-custom Illumina CanineHD array for various genome-wide association studies (GWAS) at Cornell University Hospital for Animals, we chose 353 clinically healthy, adult dogs for our analysis of clinical pathologic test results (14 hematological tests and 25 clinical chemistry tests). After correcting for age, body weight and sex, genetic associations were identified for amylase, segmented neutrophils, urea nitrogen, glucose, and mean corpuscular hemoglobin. Additionally, a strong genetic association (P = 8.1×10-13) was evident between a region of canine chromosome 13 (CFA13) and alanine aminotransferase (ALT), explaining 23% of the variation in ALT levels. This region of CFA13 encompasses the GPT gene that encodes the transferase. Dogs homozygous for the derived allele exhibit lower ALT activity, making increased ALT activity a less useful marker of hepatic injury in these individuals. Overall, these associations provide a roadmap for identifying causal variants that could improve interpretation of clinical blood tests and understanding of genetic risk factors associated with diseases such as canine diabetes and anemia, and demonstrate the utility of holistic phenotyping of dogs genotyped for disease mapping studies.
url http://europepmc.org/articles/PMC4690602?pdf=render
work_keys_str_mv AT michelleewhite geneticmappingofnovellociaffectingcaninebloodphenotypes
AT jessicajhayward geneticmappingofnovellociaffectingcaninebloodphenotypes
AT tracystokol geneticmappingofnovellociaffectingcaninebloodphenotypes
AT adamrboyko geneticmappingofnovellociaffectingcaninebloodphenotypes
_version_ 1725113180677472256